Clinical TrialsTier 1 source
EGFR-targeted antibody−toxin conjugate in recurrent glioma: a phase 1 trial
Nature Medicine
Read the full paper
This is a preview. The primary source is hosted externally — past100 links directly to the original journal paper, not a news article about it.
View original paper →Get our analysis
Each week past100 selects one paper and breaks it down: study design, effect sizes, caveats, and what a rational evidence-informed person should do with the information.
Subscribe free →